Iridium shareholders overwhelmingly approved Rocket Lab’s planned acquisition, with 99.6% of votes cast supporting the deal at a September 24, 2026, special meeting. Approximately 81% of all outstanding Iridium shares participated, while investors also approved an advisory resolution concerning executive golden parachute payments. The agreement provides $27.00 in cash plus Rocket Lab equity determined through a collared exchange ratio (share-swap formula with price protections), representing a notional value of $54.00 per Iridium share. Rocket Lab shares rose 5% to approximately $73.61, supported by the vote, the company’s position on the Space Force’s NITE-STAR contract vehicle and continued ARK Invest purchases. The transaction remains subject to regulatory clearances and other closing requirements, with both companies targeting completion by mid-2027. Rocket Lab’s stock also benefited from elevated trading volume, while analyst views remained divided and concerns persisted over financing, integration execution, valuation and the company’s continuing losses.